Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
…, RD Jackson, SAA Beresford, BV Howard, KC Johnson… - Jama, 2002 - escholarship.org
ContextDespite decades of accumulated observational evidence, the balance of risks and
benefits for hormone use in healthy postmenopausal women remains uncertain.ObjectiveTo …
benefits for hormone use in healthy postmenopausal women remains uncertain.ObjectiveTo …
[HTML][HTML] Estrogen plus progestin and the risk of coronary heart disease
JAE Manson, J Hsia, KC Johnson… - … England Journal of …, 2003 - Mass Medical Soc
Background Recent randomized clinical trials have suggested that estrogen plus progestin
does not confer cardiac protection and may increase the risk of coronary heart disease (CHD)…
does not confer cardiac protection and may increase the risk of coronary heart disease (CHD)…
[HTML][HTML] Calcium plus vitamin D supplementation and the risk of fractures
…, J Hsia, FA Hubbell, KC Johnson… - … England Journal of …, 2006 - Mass Medical Soc
Background The efficacy of calcium with vitamin D supplementation for preventing hip and
other fractures in healthy postmenopausal women remains equivocal. Methods We recruited …
other fractures in healthy postmenopausal women remains equivocal. Methods We recruited …
[BOOK][B] Vantage points
KC Johnson - 2005 - search.proquest.com
This thesis proposes a system of urban installations located throughout the city of Montreal
that would be used to explore contemporary notions of urban identity. These installations act …
that would be used to explore contemporary notions of urban identity. These installations act …
Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly …
…, JB Kostis, S Kumanyika, CR Lacy, KC Johnson… - Jama, 1998 - jamanetwork.com
Context.—Nonpharmacologic interventions are frequently recommended for treatment of
hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials …
hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials …
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials
Importance Menopausal hormone therapy continues in clinical use but questions remain
regarding its risks and benefits for chronic disease prevention. Objective To report a …
regarding its risks and benefits for chronic disease prevention. Objective To report a …
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
…, G Heiss, SL Hendrix, FA Hubbell, KC Johnson… - Jama, 2006 - jamanetwork.com
ContextMultiple epidemiologic studies and some trials have linked diet with cardiovascular
disease (CVD) prevention, but long-term intervention data are needed.ObjectiveTo test the …
disease (CVD) prevention, but long-term intervention data are needed.ObjectiveTo test the …
[HTML][HTML] Calcium plus vitamin D supplementation and the risk of colorectal cancer
…, FA Hubbell, RD Jackson, KC Johnson… - … England Journal of …, 2006 - Mass Medical Soc
Background Higher intake of calcium and vitamin D has been associated with a reduced risk
of colorectal cancer in epidemiologic studies and polyp recurrence in polyp-prevention trials…
of colorectal cancer in epidemiologic studies and polyp recurrence in polyp-prevention trials…
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial
…, ML Stefanick, DS Lane, J Hays, KC Johnson… - Jama, 2003 - jamanetwork.com
ContextObservational studies have suggested that postmenopausal hormone treatment may
improve cognitive function, but data from randomized clinical trials have been sparse and …
improve cognitive function, but data from randomized clinical trials have been sparse and …
[HTML][HTML] Exemestane for breast-cancer prevention in postmenopausal women
…, A McTiernan, J Robbins, KC Johnson… - … England Journal of …, 2011 - Mass Medical Soc
Background Tamoxifen and raloxifene have limited patient acceptance for primary prevention
of breast cancer. Aromatase inhibitors prevent more contralateral breast cancers and …
of breast cancer. Aromatase inhibitors prevent more contralateral breast cancers and …